Genus (GNS) Competitors GBX 1,993 +29.00 (+1.48%) As of 10:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, BAY, and STGShould you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Bay Capital (BAY), and Strip Tinning (STG). These companies are all part of the "personal services" industry. Genus vs. Its Competitors Howden Joinery Group Dechra Pharmaceuticals IG Group City of London WH Smith Carclo Prime People Aukett Swanke Group Bay Capital Strip Tinning Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both consumer cyclical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Is HWDN or GNS a better dividend stock? Howden Joinery Group pays an annual dividend of GBX 21 per share and has a dividend yield of 2.4%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.6%. Howden Joinery Group pays out 45.0% of its earnings in the form of a dividend. Genus pays out 265.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio. Do analysts recommend HWDN or GNS? Howden Joinery Group currently has a consensus target price of GBX 971.33, suggesting a potential upside of 10.76%. Genus has a consensus target price of GBX 2,150, suggesting a potential upside of 8.37%. Given Howden Joinery Group's higher possible upside, equities analysts clearly believe Howden Joinery Group is more favorable than Genus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Howden Joinery Group 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Genus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, HWDN or GNS? Howden Joinery Group has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Is HWDN or GNS more profitable? Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.Company Net Margins Return on Equity Return on Assets Howden Joinery Group10.82% 25.70% 10.70% Genus 1.18%1.41%3.31% Which has stronger earnings and valuation, HWDN or GNS? Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHowden Joinery Group£2.34B2.05£253.42M£46.6518.80Genus£666.67M1.95£7.87M£12.06164.46 Do institutionals & insiders believe in HWDN or GNS? 70.6% of Howden Joinery Group shares are owned by institutional investors. Comparatively, 77.8% of Genus shares are owned by institutional investors. 0.5% of Howden Joinery Group shares are owned by insiders. Comparatively, 0.8% of Genus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor HWDN or GNS? Howden Joinery Group received 315 more outperform votes than Genus when rated by MarketBeat users. Likewise, 72.37% of users gave Howden Joinery Group an outperform vote while only 70.60% of users gave Genus an outperform vote. CompanyUnderperformOutperformHowden Joinery GroupOutperform Votes66872.37% Underperform Votes25527.63% GenusOutperform Votes35370.60% Underperform Votes14729.40% Does the media prefer HWDN or GNS? In the previous week, Howden Joinery Group had 2 more articles in the media than Genus. MarketBeat recorded 3 mentions for Howden Joinery Group and 1 mentions for Genus. Howden Joinery Group's average media sentiment score of 0.47 beat Genus' score of 0.30 indicating that Howden Joinery Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Howden Joinery Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Genus 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHowden Joinery Group beats Genus on 15 of the 19 factors compared between the two stocks. Get Genus News Delivered to You Automatically Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNS vs. The Competition Export to ExcelMetricGenusBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.30B£127.96M£5.60B£2.93BDividend Yield1.69%3.74%5.28%4.90%P/E Ratio164.463.2927.23123.18Price / Sales1.954,386.11417.65243,308.49Price / Cash50.5613.1938.2528.07Price / Book2.4037.877.124.75Net Income£7.87M-£91.56M£3.23B£5.91B7 Day Performance-0.10%1.74%2.74%6.94%1 Month Performance-6.83%7.18%8.94%16.69%1 Year Performance11.46%174.10%31.59%77.68% Genus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNSGenus0.469 of 5 starsGBX 1,993+1.5%GBX 2,150+7.9%+10.5%£1.31B£666.67M165.20480Gap DownHigh Trading VolumeHWDNHowden Joinery Group2.6522 of 5 starsGBX 859.50+1.1%GBX 971.33+13.0%+2.2%£4.69B£2.34B18.4212,000Positive NewsDPHDechra PharmaceuticalsN/AN/AN/AN/A£4.40B£761.50M-15,464.002,457IGGIG Group3.1761 of 5 starsGBX 1,079.48+0.3%GBX 1,466+35.8%+35.8%£3.83B£913.00M7.202,754Positive NewsCTYCity of LondonN/AGBX 487+0.2%N/A+17.8%£2.41B£307.08M8.20N/ADividend AnnouncementSMWHWH Smith3.4265 of 5 starsGBX 1,071+1.7%GBX 1,430+33.5%-9.4%£1.38B£1.83B22.0914,935Dividend IncreaseAnalyst ForecastGap DownCARCarcloN/AGBX 38.80-2.8%N/A+109.8%£28.49M£132.66M-8.641,059PRPPrime PeopleN/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap DownAUKAukett Swanke GroupN/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap DownBAYBay CapitalN/AGBX 5.50flatN/A-13.7%£3.85MN/A-2.712Gap DownSTGStrip TinningN/AGBX 18.25-3.9%N/A-73.0%£3.33M£10.09M-1.114,060Gap Down Related Companies and Tools Related Companies Howden Joinery Group Competitors Dechra Pharmaceuticals Competitors IG Group Competitors City of London Competitors WH Smith Competitors Carclo Competitors Prime People Competitors Aukett Swanke Group Competitors Bay Capital Competitors Strip Tinning Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:GNS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.